Bausch & Lomb's Listing on New York Stock Exchange Extended.

ROCHESTER, N.Y. -- Bausch & Lomb (NYSE: BOL) today announced that it has received an additional extension for continued listing and trading on the New York Stock Exchange (NYSE). The extension, which is subject to review by the NYSE on an ongoing basis, provides the Company until March 1, 2007 to file its Annual Report on Form 10-K for the year ended December 31, 2005 with the Securities and Exchange Commission. During that period, trading of the Company's shares on the NYSE will remain unaffected. If Bausch & Lomb does not make this filing by March 1, 2007, the NYSE could either grant a final additional extension to April 2, 2007, or move forward with the initiation of suspension and delisting procedures.

Bausch & Lomb indicated that it continues to work diligently to complete the ongoing work described in its November 9, 2006 Form 12b-25, and that it will file the 2005 Form 10-K as soon as practicable.

This news release contains, among other things, certain statements of a forward-looking nature relating to future events or the future business performance of Bausch & Lomb. Such statements involve a number of risks and uncertainties including those concerning economic conditions, currency exchange rates, product development and introduction, the financial well-being of key customers, the successful execution of marketing strategies, the continued successful implementation of its efforts in managing and reducing costs and expenses, as well as the risk factors listed from time to time in the Company's SEC filings, including but not limited to those included in filings on Form 8-K and Form 12b-25, each dated August 8, 2006.

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York. Bausch & Lomb's 2004 revenues were $2.2 billion; it employs approximately 13,700 people worldwide and its products are available in more than 100 countries. More information about the Company is on the Bausch & Lomb Web site at www.bausch.com. Copyright Bausch & Lomb Incorporated.